Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke

NCT03815292 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment
Ischemic Stroke

Interventions

DRUG: MMH-MAP
DRUG: Placebo

Sponsor

Materia Medica Holding